Carrie Pallardy's profile photo

Carrie Pallardy

Chicago

Writer and Editor at Freelance

Freelance Writer and Editor

Featured in: Favicon chicagotribune.com Favicon investopedia.com Favicon informationweek.com Favicon charlotteobserver.com Favicon star-telegram.com Favicon matadornetwork.com Favicon thestate.com Favicon kansas.com Favicon beckershospitalreview.com Favicon islandpacket.com

Articles

  • Tivic adds new vagus nerve stim patent

    2 days ago | massdevice.com | Carrie Pallardy

    Tivic Health Systems (Nasdaq:TIVC) filed a patent application for its vagus nerve stimulation (VNS) system. Tivic has a portfolio of patients for its non-invasive VNS technology, and it aims to expand it with this new application. In July 2024, the health tech company added three patents granted in the U.S. and Europe, further shoring up its intellectual property portfolio.

  • Study backs Teleflex stapler for reducing post-op GERD rates

    2 days ago | massdevice.com | Carrie Pallardy

    Teleflex (NYSE: TFX)  announced the results of a study comparing the use of its Titan SGS Stapler with traditional multi-fire surgical staplers. The retrospective analysis found that the Titan SGS Stapler is associated with lower rates of postoperative GERD and shorter-than-average lengths of stay in the hospital following sleeve gastrectomy. Previous research reveals that worsening or de novo GERD is a concern following this common weight loss procedure.

  • The FDA is turning to generative AI to boost efficiency

    3 days ago | medicaldesignandoutsourcing.com | Carrie Pallardy

    The Food and Drug Administration (FDA)  plans to launch generative AI across all of its centers by June 30. The announcement follows the appointment of the agency’s first chief AI officer, Jeremy Walsh, and the completion of an AI-assisted scientific review pilot. The generative AI rollout will allow FDA staff to spend less time on “tedious, repetitive tasks,” ultimately making the review process more efficient, according to the agency.

  • Solventum beats The Street in Q1 and ups revenue guidance

    6 days ago | massdevice.com | Carrie Pallardy

    Solventum (NYSE: SOLV), spun off from 3M in April 2024, reported $2.1 billion in sales for the first quarter of 2025, an increase of 2.6%. With solid revenue growth in this quarter, the company also announced yesterday evening that it is slightly bumping up its outlook for full-year organic sales. Investors reacted by ending SOLV shares up more than 5% to $70.02 apiece by midday trading today.

  • TransMedics ups revenue guidance on strength of its organ transport tech

    6 days ago | massdevice.com | Carrie Pallardy

    TransMedics (Nasdaq: TMDX) is starting the year with a strong quarter. The Andover, Massachusetts–based medtech company, which offers an organ care system (OCS) for transplant therapy, hit $143.5 million in revenue for the first quarter, up 48% year over year, according to its Q1earnings release out after market close yesterday. The news sent TMDX shares up more than 21% to $112.77 apiece by midday trading today.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
725
Tweets
547
DMs Open
No
Carrie Pallardy
Carrie Pallardy @PallardyCarrie
13 Jun 23

RT @InformationWeek: 6 Ways to Manage Cybersecurity Burnout and Support Teams Better https://t.co/oIweL5pvS8

Carrie Pallardy
Carrie Pallardy @PallardyCarrie
2 Jun 23

#DataPrivacy is essential in #healthcare. How are #trackingpixels impacting patient privacy? @InformationWeek https://t.co/NGtuysAbAH

Carrie Pallardy
Carrie Pallardy @PallardyCarrie
10 Apr 23

https://t.co/bvPXCbEs0W How will the next generation of #datascientists shape the future of #sustainable #computing? Experts in #AI, #cloud, #datacenters, and more talk to @InformationWeek.